ARCA biopharma Announces Corporate and Gencaro(TM) Development Update
11/17/2009 9:25:41 AM
More...
|
ARCA biopharma Announces Changes to Management Team Reflecting Change in Commercial Strategy
7/6/2009 10:25:45 AM
More...
|
ARCA biopharma Receives Complete Response Letter From FDA; FDA Does Not Approve GencaroTM NDA
6/1/2009 7:34:52 AM
More...
|
ARCA biopharma to Present at the Biocentury Future Leaders in the Biotech Industry Conference
4/1/2009 9:46:21 AM
More...
|
ARCA biopharma Release: Data from Gencaro(TM) Phase 3 Best Trial Presented at the American College of Cardiology 58th Annual Scientific Session
3/30/2009 9:27:06 AM
More...
|
ARCA biopharma Release: Two Gencaro(TM) Posters to Be Presented at the American College of Cardiology 58th Annual Scientific Session
3/19/2009 10:33:41 AM
More...
|
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
2/25/2009 7:19:54 AM
More...
|
ARCA biopharma Announces Commencement of Trading on the NASDAQ Global Market Under the Symbol “ABIO”
1/28/2009 8:42:33 AM
More...
|
ARCA biopharma and Nuvelo, Inc. (NUVO) Complete Merger Creating Late-Stage Cardiovascular Company
1/28/2009 6:40:11 AM
More...
|
ARCA biopharma Appoints Derek Cole as Vice President, Investor Relations and Corporate Communications
1/12/2009 8:35:20 AM
More...
|
|